Lorenzo Berti

USPTO Granted Patents = 15 (Patent Applications = 15)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 16)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 187(Granted Patents)

Company Filing History:

Illumina Cambridge Limited

patents

2 out of 41

Element Biosciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12442039 - Resin composition and flow cells incorporating the same (2025-10-14),

2. 12241891 - Multivalent binding composition for nucleic acid analysis (2025-03-04),

3. 12202950 - Catalyst-free surface functionalization and polymer grafting (2025-01-21),

4. 12013330 - Resin composition and flow cells incorporating the same (2024-06-18),

5. 11884976 - Resin composition and flow cells incorporating the same (2024-01-30),

6. 11834704 - Microarray fabrication system and method (2023-12-05),

7. 11667957 - Methods and compositions for identifying ligands on arrays using indexes and barcodes (2023-06-06),

8. 11618808 - Catalyst-free surface functionalization and polymer grafting (2023-04-04),

9. 11287422 - Multivalent binding composition for nucleic acid analysis (2022-03-29),

10. 11060135 - Microarray fabrication system and method (2021-07-13),

11. 10975210 - Catalyst-free surface functionalization and polymer grafting (2021-04-13),

12. 10280454 - Microarray fabrication system and method (2019-05-07),

13. 9994687 - Catalyst-free surface functionalization and polymer grafting (2018-06-12),

14. 9670535 - Microarray fabrication system and method (2017-06-06),

15. 8778849 - Microarray fabrication system and method (2014-07-15),

Title: Lorenzo Berti: Innovator in Resin Composition and Nucleic Acid Analysis

Introduction

Lorenzo Berti is a prominent inventor based in San Diego, California. He holds a total of 15 patents, showcasing his significant contributions to the fields of resin composition and nucleic acid analysis. His innovative work has implications in various scientific and technological applications.

Latest Patents

Among his latest patents is a resin composition that includes a free radical curable resin matrix comprising an acrylate and a siloxane, along with a free radical photoinitiator. This resin composition exhibits low or no autofluorescence when exposed to specific blue and green excitation wavelengths. Another notable patent is for a multivalent binding composition for nucleic acid analysis. This composition features a particle-nucleotide conjugate with multiple copies of a nucleotide attached to the particle. It allows for the localization of detectable signals to active regions of biochemical interaction, enhancing the identification of sites of base incorporation during polymerase reactions.

Career Highlights

Lorenzo has worked with leading companies in the biotechnology sector, including Illumina Corporation and Illumina Cambridge Limited. His experience in these organizations has contributed to his expertise and innovative capabilities in his field.

Collaborations

Some of his notable coworkers include Andrew Antony Brown and Wayne N George. Their collaboration has likely fostered a productive environment for innovation and research.

Conclusion

Lorenzo Berti's contributions to resin composition and nucleic acid analysis highlight his role as a significant inventor in the scientific community. His patents reflect a commitment to advancing technology and improving methodologies in these critical areas.

This text is generated by artificial intelligence and may not be accurate.